LSE-listed (IPO). Founded 2001. £883m NAV + £663m 3rd party AUM (Jun 2025). 485 investments incl. Artios (pharma, Series D Nov 2025), Hysata (electrolysers), OXCCU (sustainable aviation fuel), Oxford Nanopore, Hinge Health, Featurespace. Sector-specialist investment teams (scientists, operators). Acquisitions: Parkwalk (EIS manager), Fusion IP, Touchstone Innovations. 20+ yr track record.
Investment Focus
Investment Thesis
University-linked IP commercialization. Early-to-growth stage across HealthTech, DeepTech, CleanTech. Targets defensible deep tech w/ multibillion-dollar addressable markets; climate innovators (renewables, hydrogen, sustainable fuels); novel therapeutics (oncology, fibrosis, obesity). 485+ portfolio cos, 36+ exits (incl. unicorns Oxford Nanopore, Hinge Health). UK-headquartered, global reach (N.America, Australasia). Value-add: business-building expertise, university network access, executive recruitment.
Interested in connecting?
Visit their website or reach out directly.